Suppr超能文献

环孢素对丙型肝炎病毒株复制的多种作用。

Diverse effects of cyclosporine on hepatitis C virus strain replication.

作者信息

Ishii Naoto, Watashi Koichi, Hishiki Takayuki, Goto Kaku, Inoue Daisuke, Hijikata Makoto, Wakita Takaji, Kato Nobuyuki, Shimotohno Kunitada

机构信息

Laboratory of Human Tumor Viruses, Department of Viral Oncology, Institute for Virus Research, Kyoto University, 53 Kawaharacho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

出版信息

J Virol. 2006 May;80(9):4510-20. doi: 10.1128/JVI.80.9.4510-4520.2006.

Abstract

Recently, a production system for infectious particles of hepatitis C virus (HCV) utilizing the genotype 2a JFH1 strain has been developed. This strain has a high capacity for replication in the cells. Cyclosporine (CsA) has a suppressive effect on HCV replication. In this report, we characterize the anti-HCV effect of CsA. We observe that the presence of viral structural proteins does not influence the anti-HCV activity of CsA. Among HCV strains, the replication of genotype 1b replicons was strongly suppressed by treatment with CsA. In contrast, JFH1 replication was less sensitive to CsA and its analog, NIM811. Replication of JFH1 did not require the cellular replication cofactor, cyclophilin B (CyPB). CyPB stimulated the RNA binding activity of NS5B in the genotype 1b replicon but not the genotype 2a JFH1 strain. These findings provide an insight into the mechanisms of diversity governing virus-cell interactions and in the sensitivity of these strains to antiviral agents.

摘要

最近,一种利用丙型肝炎病毒(HCV)2a基因型JFH1株生产感染性病毒颗粒的系统已被开发出来。该毒株在细胞中具有高复制能力。环孢素(CsA)对HCV复制有抑制作用。在本报告中,我们对CsA的抗HCV作用进行了表征。我们观察到病毒结构蛋白的存在并不影响CsA的抗HCV活性。在HCV毒株中,1b基因型复制子的复制受到CsA处理的强烈抑制。相比之下,JFH1的复制对CsA及其类似物NIM811不太敏感。JFH1的复制不需要细胞复制辅助因子亲环素B(CyPB)。CyPB刺激了1b基因型复制子中NS5B的RNA结合活性,但对2a基因型JFH1毒株没有刺激作用。这些发现为控制病毒-细胞相互作用的多样性机制以及这些毒株对抗病毒药物的敏感性提供了见解。

相似文献

1
Diverse effects of cyclosporine on hepatitis C virus strain replication.
J Virol. 2006 May;80(9):4510-20. doi: 10.1128/JVI.80.9.4510-4520.2006.
2
HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A.
Arch Virol. 2009;154(10):1671-7. doi: 10.1007/s00705-009-0502-x. Epub 2009 Sep 25.
3
Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.
Cancer Sci. 2009 Oct;100(10):1943-50. doi: 10.1111/j.1349-7006.2009.01263.x. Epub 2009 Jun 26.
5
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.
Hepatology. 2009 Nov;50(5):1638-45. doi: 10.1002/hep.23281.
6
Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
Biochim Biophys Acta. 2012 Dec;1820(12):1886-92. doi: 10.1016/j.bbagen.2012.08.017. Epub 2012 Aug 28.
7
Resistance to cyclosporin A derives from mutations in hepatitis C virus nonstructural proteins.
Biochem Biophys Res Commun. 2014 May 23;448(1):56-62. doi: 10.1016/j.bbrc.2014.04.053. Epub 2014 Apr 19.
9
Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.
J Virol. 2007 Jun;81(11):5829-40. doi: 10.1128/JVI.02524-06. Epub 2007 Mar 21.
10
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Hepatology. 2003 Nov;38(5):1282-8. doi: 10.1053/jhep.2003.50449.

引用本文的文献

2
The Cyclophilin-Dependent Calcineurin Inhibitor Voclosporin Inhibits SARS-CoV-2 Replication in Cell Culture.
Transpl Int. 2022 Jun 24;35:10369. doi: 10.3389/ti.2022.10369. eCollection 2022.
4
The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region.
J Mol Biol. 2021 Jul 23;433(15):167108. doi: 10.1016/j.jmb.2021.167108. Epub 2021 Jun 20.
5
Low-dose cyclosporine for active lupus nephritis: a dose titration approach.
Clin Rheumatol. 2019 Aug;38(8):2151-2159. doi: 10.1007/s10067-019-04469-6. Epub 2019 Apr 1.
7
Cyclophilins and cyclophilin inhibitors in nidovirus replication.
Virology. 2018 Sep;522:46-55. doi: 10.1016/j.virol.2018.06.011. Epub 2018 Jul 12.
8
The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
Clin Rev Allergy Immunol. 2017 Jun;52(3):401-423. doi: 10.1007/s12016-016-8582-3.
9
Chaperones in hepatitis C virus infection.
World J Hepatol. 2016 Jan 8;8(1):9-35. doi: 10.4254/wjh.v8.i1.9.
10
Hepatitis C virus utilizes VLDLR as a novel entry pathway.
Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):188-93. doi: 10.1073/pnas.1506524113. Epub 2015 Dec 23.

本文引用的文献

1
Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
J Clin Microbiol. 2005 Nov;43(11):5679-84. doi: 10.1128/JCM.43.11.5679-5684.2005.
3
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.
Mol Cell. 2005 Jul 1;19(1):111-22. doi: 10.1016/j.molcel.2005.05.014.
4
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
Nat Med. 2005 Jul;11(7):791-6. doi: 10.1038/nm1268. Epub 2005 Jun 12.
5
Complete replication of hepatitis C virus in cell culture.
Science. 2005 Jul 22;309(5734):623-6. doi: 10.1126/science.1114016. Epub 2005 Jun 9.
6
Robust hepatitis C virus infection in vitro.
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9294-9. doi: 10.1073/pnas.0503596102. Epub 2005 Jun 6.
8
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
J Virol. 2004 Dec;78(23):12800-8. doi: 10.1128/JVI.78.23.12800-12808.2004.
9
Pathogenesis of hepatitis C-associated hepatocellular carcinoma.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S62-71. doi: 10.1053/j.gastro.2004.09.017.
10
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.
Gastroenterology. 2003 Dec;125(6):1808-17. doi: 10.1053/j.gastro.2003.09.023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验